The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global EPA DHA ALA (Omega 3) Market Research Report 2025
Synopsis
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
The global EPA DHA ALA (Omega 3) market was valued at US$ 13340 million in 2023 and is anticipated to reach US$ 17220 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Global Omega-3 main players are DSM, BASF, Marine Ingredients, OLVEA Fish Oils, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 35%.
This report aims to provide a comprehensive presentation of the global market for EPA DHA ALA (Omega 3), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EPA DHA ALA (Omega 3).
Report Scope
The EPA DHA ALA (Omega 3) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global EPA DHA ALA (Omega 3) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EPA DHA ALA (Omega 3) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma
GC Rieber
Polaris
Auqi
Segment by Type
Fish Oil
Algae Oil
Segment by Application
Dietary Supplements
Functional Foods & Beverages
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of EPA DHA ALA (Omega 3) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of EPA DHA ALA (Omega 3) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
The global EPA DHA ALA (Omega 3) market was valued at US$ 13340 million in 2023 and is anticipated to reach US$ 17220 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Global Omega-3 main players are DSM, BASF, Marine Ingredients, OLVEA Fish Oils, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 35%.
This report aims to provide a comprehensive presentation of the global market for EPA DHA ALA (Omega 3), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EPA DHA ALA (Omega 3).
Report Scope
The EPA DHA ALA (Omega 3) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global EPA DHA ALA (Omega 3) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EPA DHA ALA (Omega 3) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma
GC Rieber
Polaris
Auqi
Segment by Type
Fish Oil
Algae Oil
Segment by Application
Dietary Supplements
Functional Foods & Beverages
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of EPA DHA ALA (Omega 3) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of EPA DHA ALA (Omega 3) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 EPA DHA ALA (Omega 3) Market Overview
1.1 Product Overview and Scope of EPA DHA ALA (Omega 3)
1.2 EPA DHA ALA (Omega 3) Segment by Type
1.2.1 Global EPA DHA ALA (Omega 3) Market Value Comparison by Type (2024-2030)
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 EPA DHA ALA (Omega 3) Segment by Application
1.3.1 Global EPA DHA ALA (Omega 3) Market Value by Application: (2024-2030)
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Global EPA DHA ALA (Omega 3) Market Size Estimates and Forecasts
1.4.1 Global EPA DHA ALA (Omega 3) Revenue 2019-2030
1.4.2 Global EPA DHA ALA (Omega 3) Sales 2019-2030
1.4.3 Global EPA DHA ALA (Omega 3) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 EPA DHA ALA (Omega 3) Market Competition by Manufacturers
2.1 Global EPA DHA ALA (Omega 3) Sales Market Share by Manufacturers (2019-2024)
2.2 Global EPA DHA ALA (Omega 3) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global EPA DHA ALA (Omega 3) Average Price by Manufacturers (2019-2024)
2.4 Global EPA DHA ALA (Omega 3) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of EPA DHA ALA (Omega 3), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of EPA DHA ALA (Omega 3), Product Type & Application
2.7 EPA DHA ALA (Omega 3) Market Competitive Situation and Trends
2.7.1 EPA DHA ALA (Omega 3) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest EPA DHA ALA (Omega 3) Players Market Share by Revenue
2.7.3 Global EPA DHA ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 EPA DHA ALA (Omega 3) Retrospective Market Scenario by Region
3.1 Global EPA DHA ALA (Omega 3) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global EPA DHA ALA (Omega 3) Global EPA DHA ALA (Omega 3) Sales by Region: 2019-2030
3.2.1 Global EPA DHA ALA (Omega 3) Sales by Region: 2019-2024
3.2.2 Global EPA DHA ALA (Omega 3) Sales by Region: 2025-2030
3.3 Global EPA DHA ALA (Omega 3) Global EPA DHA ALA (Omega 3) Revenue by Region: 2019-2030
3.3.1 Global EPA DHA ALA (Omega 3) Revenue by Region: 2019-2024
3.3.2 Global EPA DHA ALA (Omega 3) Revenue by Region: 2025-2030
3.4 North America EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.4.1 North America EPA DHA ALA (Omega 3) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America EPA DHA ALA (Omega 3) Sales by Country (2019-2030)
3.4.3 North America EPA DHA ALA (Omega 3) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.5.1 Europe EPA DHA ALA (Omega 3) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe EPA DHA ALA (Omega 3) Sales by Country (2019-2030)
3.5.3 Europe EPA DHA ALA (Omega 3) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.6.1 Asia Pacific EPA DHA ALA (Omega 3) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific EPA DHA ALA (Omega 3) Sales by Country (2019-2030)
3.6.3 Asia Pacific EPA DHA ALA (Omega 3) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.7.1 Latin America EPA DHA ALA (Omega 3) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America EPA DHA ALA (Omega 3) Sales by Country (2019-2030)
3.7.3 Latin America EPA DHA ALA (Omega 3) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa EPA DHA ALA (Omega 3) Market Facts & Figures by Country
3.8.1 Middle East and Africa EPA DHA ALA (Omega 3) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa EPA DHA ALA (Omega 3) Sales by Country (2019-2030)
3.8.3 Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global EPA DHA ALA (Omega 3) Sales by Type (2019-2030)
4.1.1 Global EPA DHA ALA (Omega 3) Sales by Type (2019-2024)
4.1.2 Global EPA DHA ALA (Omega 3) Sales by Type (2025-2030)
4.1.3 Global EPA DHA ALA (Omega 3) Sales Market Share by Type (2019-2030)
4.2 Global EPA DHA ALA (Omega 3) Revenue by Type (2019-2030)
4.2.1 Global EPA DHA ALA (Omega 3) Revenue by Type (2019-2024)
4.2.2 Global EPA DHA ALA (Omega 3) Revenue by Type (2025-2030)
4.2.3 Global EPA DHA ALA (Omega 3) Revenue Market Share by Type (2019-2030)
4.3 Global EPA DHA ALA (Omega 3) Price by Type (2019-2030)
5 Segment by Application
5.1 Global EPA DHA ALA (Omega 3) Sales by Application (2019-2030)
5.1.1 Global EPA DHA ALA (Omega 3) Sales by Application (2019-2024)
5.1.2 Global EPA DHA ALA (Omega 3) Sales by Application (2025-2030)
5.1.3 Global EPA DHA ALA (Omega 3) Sales Market Share by Application (2019-2030)
5.2 Global EPA DHA ALA (Omega 3) Revenue by Application (2019-2030)
5.2.1 Global EPA DHA ALA (Omega 3) Revenue by Application (2019-2024)
5.2.2 Global EPA DHA ALA (Omega 3) Revenue by Application (2025-2030)
5.2.3 Global EPA DHA ALA (Omega 3) Revenue Market Share by Application (2019-2030)
5.3 Global EPA DHA ALA (Omega 3) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 EPAX
6.1.1 EPAX Corporation Information
6.1.2 EPAX Description and Business Overview
6.1.3 EPAX EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 EPAX EPA DHA ALA (Omega 3) Product Portfolio
6.1.5 EPAX Recent Developments/Updates
6.2 Golden Omega
6.2.1 Golden Omega Corporation Information
6.2.2 Golden Omega Description and Business Overview
6.2.3 Golden Omega EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Golden Omega EPA DHA ALA (Omega 3) Product Portfolio
6.2.5 Golden Omega Recent Developments/Updates
6.3 TASA
6.3.1 TASA Corporation Information
6.3.2 TASA Description and Business Overview
6.3.3 TASA EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TASA EPA DHA ALA (Omega 3) Product Portfolio
6.3.5 TASA Recent Developments/Updates
6.4 Omega Protein
6.4.1 Omega Protein Corporation Information
6.4.2 Omega Protein Description and Business Overview
6.4.3 Omega Protein EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Omega Protein EPA DHA ALA (Omega 3) Product Portfolio
6.4.5 Omega Protein Recent Developments/Updates
6.5 Croda
6.5.1 Croda Corporation Information
6.5.2 Croda Description and Business Overview
6.5.3 Croda EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Croda EPA DHA ALA (Omega 3) Product Portfolio
6.5.5 Croda Recent Developments/Updates
6.6 KD Pharma
6.6.1 KD Pharma Corporation Information
6.6.2 KD Pharma Description and Business Overview
6.6.3 KD Pharma EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 KD Pharma EPA DHA ALA (Omega 3) Product Portfolio
6.6.5 KD Pharma Recent Developments/Updates
6.7 GC Rieber
6.6.1 GC Rieber Corporation Information
6.6.2 GC Rieber Description and Business Overview
6.6.3 GC Rieber EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GC Rieber EPA DHA ALA (Omega 3) Product Portfolio
6.7.5 GC Rieber Recent Developments/Updates
6.8 Polaris
6.8.1 Polaris Corporation Information
6.8.2 Polaris Description and Business Overview
6.8.3 Polaris EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Polaris EPA DHA ALA (Omega 3) Product Portfolio
6.8.5 Polaris Recent Developments/Updates
6.9 Auqi
6.9.1 Auqi Corporation Information
6.9.2 Auqi Description and Business Overview
6.9.3 Auqi EPA DHA ALA (Omega 3) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Auqi EPA DHA ALA (Omega 3) Product Portfolio
6.9.5 Auqi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 EPA DHA ALA (Omega 3) Industry Chain Analysis
7.2 EPA DHA ALA (Omega 3) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 EPA DHA ALA (Omega 3) Production Mode & Process
7.4 EPA DHA ALA (Omega 3) Sales and Marketing
7.4.1 EPA DHA ALA (Omega 3) Sales Channels
7.4.2 EPA DHA ALA (Omega 3) Distributors
7.5 EPA DHA ALA (Omega 3) Customers
8 EPA DHA ALA (Omega 3) Market Dynamics
8.1 EPA DHA ALA (Omega 3) Industry Trends
8.2 EPA DHA ALA (Omega 3) Market Drivers
8.3 EPA DHA ALA (Omega 3) Market Challenges
8.4 EPA DHA ALA (Omega 3) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
